Management of Refractory Glaucoma, a New Surgical Paradigm: Review of the Literature.

IF 1.7 4区医学 Q3 OPHTHALMOLOGY

Current Eye Research Pub Date : 2025-04-21 DOI:10.1080/02713683.2025.2494799

Victoria Heintz, Paul Bastelica, Christophe Baudouin, Yves Lachkar, Antoine Labbé

{"title":"Management of Refractory Glaucoma, a New Surgical Paradigm: Review of the Literature.","authors":"Victoria Heintz, Paul Bastelica, Christophe Baudouin, Yves Lachkar, Antoine Labbé","doi":"10.1080/02713683.2025.2494799","DOIUrl":null,"url":null,"abstract":"Purpose: To review current therapeutic strategies and innovations in the management of refractory glaucoma, with a focus on recent advancements in implantable surgical devices.Methods: A comprehensive literature search across PubMed, Embase, and Cochrane Library, included terms such as \"refractory glaucoma,\" \"posterior drainage implants,\" \"cyclodestruction,\" and \"minimally invasive glaucoma surgery.\" Articles discussing surgical and medical interventions, as well as device innovations, were included.Results: Therapeutic options include creating new sites for filtering surgery, posterior drainage implants, minimally invasive devices, cyclodestruction, or continuing medical management without surgery.Conclusion: Therapeutic decisions regarding refractory glaucoma should be made on a thoughtful, individualized basis, carefully weighing the expected benefits against the potential risks for the patient. Recent innovations in implantable devices expand the range of surgical possibilities.","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":" ","pages":"1-14"},"PeriodicalIF":1.7000,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Eye Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/02713683.2025.2494799","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To review current therapeutic strategies and innovations in the management of refractory glaucoma, with a focus on recent advancements in implantable surgical devices.

Methods: A comprehensive literature search across PubMed, Embase, and Cochrane Library, included terms such as "refractory glaucoma," "posterior drainage implants," "cyclodestruction," and "minimally invasive glaucoma surgery." Articles discussing surgical and medical interventions, as well as device innovations, were included.

Results: Therapeutic options include creating new sites for filtering surgery, posterior drainage implants, minimally invasive devices, cyclodestruction, or continuing medical management without surgery.

Conclusion: Therapeutic decisions regarding refractory glaucoma should be made on a thoughtful, individualized basis, carefully weighing the expected benefits against the potential risks for the patient. Recent innovations in implantable devices expand the range of surgical possibilities.

查看原文本刊更多论文

难治性青光眼的治疗：一种新的手术模式：文献综述。

目的：回顾目前难治性青光眼的治疗策略和创新，重点介绍植入式手术装置的最新进展。方法：在PubMed、Embase和Cochrane图书馆进行综合文献检索，包括“难治性青光眼”、“后路引流植入物”、“环破坏”和“微创青光眼手术”等术语。包括讨论外科和医疗干预以及设备创新的文章。结果：治疗选择包括建立新的部位进行过滤手术、后路引流植入物、微创装置、环破坏或不进行手术的持续医疗管理。结论：对难治性青光眼的治疗决策应在深思熟虑、个体化的基础上做出，仔细权衡患者的预期获益和潜在风险。最近植入式装置的创新扩大了手术的可能性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Eye Research 医学-眼科学

CiteScore

4.60

自引率

0.00%

发文量

163

审稿时长

12 months

期刊介绍： The principal aim of Current Eye Research is to provide rapid publication of full papers, short communications and mini-reviews, all high quality. Current Eye Research publishes articles encompassing all the areas of eye research. Subject areas include the following: clinical research, anatomy, physiology, biophysics, biochemistry, pharmacology, developmental biology, microbiology and immunology.